上海生物芯片(SBC) (Shbioship(SBC))

上海生物芯片(SBC)

上海生物芯片有限公司(Shanghai Biochip Co. Ltd)成立于2001年8月，公司由上海创业投资有限公司、中科院上海生命科学研究院等十一家在上海的国内知名大学、研究院、医院和企业共同组建而成。2003年2月，国家发展与改革委员会批准上海生物芯片有限公司负责建设和运行“生物芯片上海国家工程研究中心”。

公司主营业务为生物芯片的技术创新与服务、产品开发、生产与销售。公司致力于生物芯片在生命科学研究、医疗保健、食品安全和药物开发等领域的应用和推广，为人类健康造福。

抢占国际生物技术制高点 全面推进国家生物芯片产业化

公司愿景(SBC Vision)：

成为国家生物芯片技术创新和产业化基地；成为国内一流、国际知名的骨干生物技术企业。

公司使命(SBC Mission)：

应用生物芯片和功能基因组核心技术及先进成果，面向现代生物医药健康市场，成为系统生物学研究技术和服务的提供者；分子诊断技术与产品的提供者；药物开发技术与产品的提供者。

公司价值(SBC Value)：

科研创新、市场导向、以人为本

SBC is one of the largest biotech companies in China established in August 2001. The company owns a vast campus of greater than 400,000 square feet (about 10 acres), with research building space of over 200,000 square feet, located at Shanghai Zhangjiang Hi-Tech Park in Pudong.SBC has received nvestments totaling $45 million USD from government grants and 10 shareholders consisting of top VC groups, universities, research institutes, hospitals, and large biopharma at Shanghai.

SBC is also the national Engineering Center for biochip design and engineering in Shanghai.With advanced biotech platforms, GLP, GCP and GMP labs, and strong teams for research, services, marketing and sales, we provide not only a series of biochips and related technical services, but also proprietary drug targets and relevant diagnostic products. SBC currently collaborates with several top ten worldwide Pharmaceutical companies and leading diagnostic products providers located in the USA, Europe and China.

SBC was founded in 2001 with total of US$50 million by Chinese government grant and 11 share holders consisting of all top academic universities, research institutes, hospitals, and famous biotech companies in Shanghai.

SBC Vision:

Our Vision is to be the world leading Biotechnology Company based on the continual pursuit of scientific and operational excellence.

SBC Mission:

Our Mission is to develop and commercializes a broad range of products and services, including biochip products, to address significant unmet needs in drug discovery research, systems biology research, clinical applications and bio-safety testing.

SBC Value:

Science innovation, Business orientation, Career development.

MaxyBio Corporation is the USA-based subsidiary of Shanghai Biochip Co. Ltd, also known as ShanghaiBio Corporation (SBC), one of the largest biotech companies in China.MaxyBio provides biopharma R&D services from biochips to drug targets,from systems biology to pharmacogenomics, and from non-clinical researches to clinical trials

With broad connections and resources in both USA and China,MaxyBio will help global Biotech,pharmaceutical and medical companies to find their best Chinese partners for research collaborations, outsourcing, and manufacturing, and distribute their new products or technology services in China market.Local office in USA, MaxyBio Corporation to handle Export/import tissue, DNA, RNA biological materials Contracts / quotation / invoice / payment Project management Local Customer support

上海伯豪生物技术有限公司（简称：伯豪生物，英文名：Shanghai Biotechnology Corporation）2008 年 12 月成立，是生物芯片国家工程研究中心的有机组成部分，专注于提供专业的生物医药和疾病诊断创新技术、产品和优质服务。

伯豪生物自成立以来获得了国家基因检测技术应用示范中心、国家工信部专精特新“小巨人”企业、院士专家工作站、高新技术企业、上海市研发公共服务平台（负责“上海市高通量疾病标志物服务平台”和“上海市基因芯片专业服务平台”的运营）、上海市服务外包公共平台、上海科技小巨人企业、浦东新区企业研发机构、联合实验室建设等一系列资质，拥有医疗机构执业许可证、医疗器械经营许可证。

伯豪生物于 2016 年入选国家发展和改革委员会首批基因检测技术应用示范中心，与复旦大学附属肿瘤医院、上海市胸科医院、上海市儿童医院、上海生物信息技术研究中心等单位共同承担运行“高发肿瘤及遗传性疾病基因检测示范中心”。

伯豪生物建立了规范化的质量控制体系，通过了 ISO9001:2015 质量技术体系的认证，并参照 GLP- L 的标准，通过 156 个 SOP 文件对项目、样品、实验过程、生物信息分析过程、数据信息管理、保密等进行严格质控。

伯豪生物累计技术服务 10 余年，承接项目数超 10000 个，用户单位 3000 家以上，累计处理样品超过 30 万份，协助客户发表论文 2000 余篇，总影响因子（IF）超 10000 分，平均影响因子（IF）大于 5 分。全面推动中国基因组学服务产业发展。可靠的质量已经得到了国内及国际科研领域的认可！伯豪生物秉承着“服务科技创新，护航人类健康！”的使命，为每一位伯豪生物客户提供专注、专业、高效的科研技术服务。

伯豪生物经过十多年不断投入和持续打造，伯豪生物已经成长为一家硬件精良，人才合理，技术专业，管理规范，理念先进，符合国际标准的以技术开发和技术服务见长的生物技术公司。